Natalie J Ives

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. ncbi Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
  2. ncbi Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
  3. ncbi Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
  4. ncbi Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
  5. ncbi Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
  6. ncbi High-dose chemotherapy for breast cancer
    Keith Wheatley
    N Engl J Med 349:1476-9; author reply 1476-9. 2003
  7. ncbi Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007

Collaborators

  • Keith Wheatley
  • Paul Lorigan
  • C E Clarke
  • Adrian Williams
  • Dwomoa Adu
  • D Grossett
  • S Holloway
  • N Heywood
  • A Jenkins
  • N Fletcher
  • L Zrinzo
  • M Silverdale
  • J Candalario
  • P Buttery
  • J Dick
  • P Limousin
  • J Wright
  • S Basu
  • S Gill
  • Thelekat Varma
  • C Watts
  • M Radatz
  • J Kausar
  • Rosalind Mitchell
  • S Khan
  • P Plaha
  • N Hulse
  • M Samuel
  • A Williams
  • C Young
  • G Sawle
  • C Keeley
  • A Lees
  • N Patel
  • R Selway
  • J Rowe
  • Caroline Rick
  • T R K Varma
  • U Brechany
  • H Pall
  • M Kellett
  • P Eldridge
  • R Swingler
  • S Eljamel
  • M Hariz
  • L Nelson
  • A Franks
  • H Watson
  • P Richardson
  • R Gregory
  • T Aziz
  • Richard Scott
  • K Ashkan
  • P Cotton
  • J Martey
  • Steven Gill
  • C Clough
  • K Anderton
  • T Murphy
  • D Burn
  • Crispin Jenkinson
  • L Mooney
  • Niall Quinn
  • R Mitchell
  • C Fletcher
  • T Foltynie
  • N Quinn
  • L Dunn
  • Jane Daniels
  • A Duffy
  • Smitaa Patel
  • R Grunewald
  • Paul Cockwell
  • Jonathan Shaw

Detail Information

Publications7

  1. ncbi Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
    ..We aimed to assess whether surgery and best medical therapy improved self-reported quality of life more than best medical therapy alone in patients with advanced Parkinson's disease...
  2. ncbi Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
    ..To study the effect of revascularization on blood pressure (BP) and serum creatinine (SCr) in patients with atherosclerotic renovascular disease (ARVD)...
  3. ncbi Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
    ..To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease...
  4. ncbi Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
    ..The only subgroup analysis performed was by type of immunotherapy, with trials divided according to whether IFN only or IFN and IL-2 were administered in the biochemotherapy arm...
  5. ncbi Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
    ..To study the effect of interleukin-2 receptor monoclonal antibodies on acute rejection episodes, graft loss, deaths, and rate of infection and malignancy in patients with renal transplants...
  6. ncbi High-dose chemotherapy for breast cancer
    Keith Wheatley
    N Engl J Med 349:1476-9; author reply 1476-9. 2003
  7. ncbi Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007